In response to recent news of the cancellation of funding for the Diabetes Prevention Program Outcomes Study (DPPOS), the long-term follow-up of the Diabetes Prevention Program (DPP), the American Diabetes Association® (ADA) issued the following statement:
“The ADA is extremely concerned about the impact of canceled National Institutes of Health funding on the success of the DPPOS, and the resulting support for people at risk of type 2 diabetes.
Eliminating funding for the DPP/DPPOS 30-year nationwide study of program participants means the loss of a decade’s worth of important findings and progress toward diabetes prevention and understanding Alzheimer’s disease and associated dementia in diabetes, a recent focus of the study. The ADA is engaging with congressional leaders on diabetes and the Trump administration to express our concerns, especially as this funding decision seems to be at odds with the Department of Health and Human Services’ commitment to combatting chronic disease in the United States.”
###
About the American Diabetes Association
The American Diabetes Association (ADA) is the nation’s leading voluntary health organization fighting to end diabetes and helping people thrive. This year, the ADA celebrates 85 years of driving discovery and research to prevent, manage, treat, and ultimately cure —and we’re not stopping. There are 136 million Americans living with diabetes or prediabetes. Through advocacy, program development, and education, we’re fighting for them all. To learn more or to get involved, visit us at diabetes.org or call 1-800-DIABETES (800-342-2383). Join us in the fight on Facebook (American Diabetes Association), Spanish Facebook (Asociación Americana de la Diabetes), LinkedIn (American Diabetes Association), and Instagram (@AmDiabetesAssn). To learn more about how we are advocating for everyone affected by diabetes, visit us on X (@AmDiabetesAssn).
